Subingsubing, Matt .

HRN: 20-78-26  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2026
CEFTRIAXONE 1G (VIAL)
02/16/2026
02/22/2026
IV
650mg
Q12
Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: